EX-10.1 2 d478169dex101.htm TRANSITION AND SEPARATION LETTER AGREEMENT February 1, 2013 Via Hand Delivery Michelle Burris Re: Terms of Transition and Separation Dear Michelle:Employment Agreement • May 5th, 2020 • Washington
Contract Type FiledMay 5th, 2020 JurisdictionThis letter confirms the agreement (“Agreement”) between you and OncoGenex Pharmaceuticals, Inc. (the “Company”) concerning the terms of your transition and separation from employment and offers you certain benefits in exchange for a general release of claims and covenant not to sue upon termination of your employment and upon the termination of the Consultancy (as defined below), as provided in further detail below. If you agree to abide by the terms outlined in this letter, please sign and return this letter to me no later than February 1, 2013.
February 1, 2013Employment Agreement • February 4th, 2013 • Oncogenex Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Washington
Contract Type FiledFebruary 4th, 2013 Company Industry JurisdictionThis letter confirms the agreement (“Agreement”) between you and OncoGenex Pharmaceuticals, Inc. (the “Company”) concerning the terms of your transition and separation from employment and offers you certain benefits in exchange for a general release of claims and covenant not to sue upon termination of your employment and upon the termination of the Consultancy (as defined below), as provided in further detail below. If you agree to abide by the terms outlined in this letter, please sign and return this letter to me no later than February 1, 2013.